Literature DB >> 8946823

Fas ligand and immune evasion.

S Nagata.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8946823     DOI: 10.1038/nm1296-1306

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

1.  Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion.

Authors:  B Frankel; S L Longo; G W Canute
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.

Authors:  H G Zhang; G Bilbao; T Zhou; J L Contreras; J Gómez-Navarro; M Feng; I Saito; J D Mountz; D T Curiel
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 3.  Recent advances in the treatment of malignant melanoma with gene therapy.

Authors:  E M Hersh; A T Stopeck
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

4.  Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma.

Authors:  Shunichi Tsujitani; Hiroaki Saito; Shinichi Oka; Teruhisa Sakamoto; Shingo Kanaji; Shigeru Tatebe; Masahide Ikeguchi
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

5.  The fas and fas ligand pathways in liver allograft tolerance.

Authors:  T L Pan; S Goto; Y C Lin; R Lord; K C Chiang; C Y Lai; Y S Chen; H L Eng; Y F Cheng; T Tatsuma; S Kitano; C L Lin; C L Chen
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

6.  Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.

Authors:  Sarika Daripally; Sateesh Reddy Nallapalle; Saritha Katta; Vidudala V T S Prasad
Journal:  Tumour Biol       Date:  2015-05-06

7.  A targeted DNA vaccine encoding fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis.

Authors:  G Wildbaum; J Westermann; G Maor; N Karin
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

8.  Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2.

Authors:  B Frankel; S L Longo; T C Ryken
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

9.  FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts.

Authors:  Aya Miyagawa-Hayashino; Tatsuaki Tsuruyama; Hiroto Egawa; Hironori Haga; Hiromi Sakashita; Tomoko Okuno; Shinya Toyokuni; Keiji Tamaki; Hirohiko Yamabe; Toshiaki Manabe; Shinji Uemoto
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

10.  Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression.

Authors:  Wen-Horng Wang; Gérald Grégori; Ronald L Hullinger; Ourania M Andrisani
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.